The Prevalence of the Metabolic Syndrome in a Danish Population of Women with Previous Gestational Diabetes Mellitus Is Three-Fold Higher than in the General Population
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Context: Diabetes and obesity, components of the metabolic syndrome, are common characteristics of women with prior gestational diabetes mellitus (GDM). Due to increasing incidence of diabetes and obesity, the metabolic syndrome might comprise a major health problem among these women. Objective: The objective was to estimate the prevalence of the metabolic syndrome by three different criteria [World Health Organization 1999 (WHO), The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001, and European Group for the Study of Insulin Resistance 2002] among women with previous GDM. Design: We conducted a follow-up study of a Danish cohort of women admitted in 1978–1996 to the Diabetes and Pregnancy Center, Rigshospitalet, Copenhagen University Hospital, with diet-treated GDM. The follow-up took place in 2000–2002 at median 9.8 yr (interquartile range 6.4–17.2) after pregnancy. Results were compared with a control group of 1000 age-matched women from a population-based sample (Inter99). Participants: Four hundred eighty-one women at median age 43 yr (interquartile range 38–48) participated. Main Outcome Measures: The main outcome measures were body mass index (BMI), glucose tolerance, blood pressure, lipid profile, and insulin resistance. Results: Independent of the criteria, the prevalence of the metabolic syndrome was three times higher in the prior GDM group, compared with the control group (e.g. WHO: 38.4 vs. 13.4%, P < 0.0005). Age- and BMI-adjusted odds ratio for having the WHO-defined metabolic syndrome was 3.4 (95% confidence interval 2.5–4.8) for the prior GDM group vs. the control group. Obese women (BMI > 30 kg/m2) with previous GDM had a more than 7-fold increased prevalence of the metabolic syndrome (WHO), compared with normal-weight prior GDM women (BMI < 25 kg/m2). In glucose-tolerant women, the prevalence was doubled in the prior GDM group, compared with control group. Conclusion: The prevalence of the metabolic syndrome was three times as high in women with prior diet-treated GDM, compared with age-matched control subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women who have had gestational diabetes are at high risk for the later development of impaired fasting glucose, impaired glucose tolerance, overt diabetes (91–93), and the metabolic syndrome (91, 94–106).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [96]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Self-citationDamm, P., Houshmand-Oeregaard, A., Kelstrup, L., Lauenborg, J., Mathiesen, E. R., & Clausen, T. D. (2016) · Diabetologia · doi:10.1007/s00125-016-3985-5 · Cited by 620
“In accordance with other studies, we found that increasing pre-pregnancy BMI, higher fasting glucose at GDM diagnosis, early gestational age at GDM diagnosis and post-partum impaired glucose tolerance were risk factors for the subsequent development of overt diabetes.”
InfluentialSelf-citationDiabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489
Rich-Edwards, J. W., Fraser, A., Lawlor, D. A., & Catov, J. M. (2014) · Epidemiologic Reviews · doi:10.1093/epirev/mxt006 · Cited by 417
“Although studies are not unanimous (132, 133), women with a history of GDM are more likely to have hypertension (134, 135), vascular dysfunction (136), impaired endothelium-dependent vasodilatation (137), and higher carotid artery intima-media thickness (138).”
BackgroundSkinner, M. K., Manikkam, M., Tracey, R., Guerrero-Bosagna, C., Haque, M., & Nilsson, E. E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-228 · Cited by 407
“Other obesity-associated conditions include type 2 diabetes [40], non-alcoholic fatty liver disease [41], obstructive sleep apnea [42], kidney/renal disease [43] and testis disease and male infertility [44].”
BackgroundRyckman, K., Spracklen, C., Smith, C., Robinson, J., & Saftlas, A. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13261 · Cited by 402
Fraser, A., Nelson, S. M., Macdonald-Wallis, C., Cherry, L., Butler, E., Sattar, N., & Lawlor, D. A. (2012) · Circulation · doi:10.1161/circulationaha.111.044784 · Cited by 401
Thompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Gestational diabetes: A clinical update
Kampmann, U. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1065 · Cited by 325
Song, C., Lyu, Y., Li, C., Liu, P., Li, J., Ma, R. C., & Yang, X. (2018) · Obesity Reviews · doi:10.1111/obr.12645 · Cited by 293
“Twenty five cohorts reported the diagnostic criteria for diabetes being used: 7 utilized the WHO’s 1985 criteria (17,18,22,23,33,39,44), 6 with the ADA’s (24,27,30,38,43,45), 5 used the WHO’s 1999 criteria (1999) (18,25,29,34,46), 4 used local or self-reported criteria (31,35,36,41), 1 with the National Diabetes Surve…”
BackgroundMethodPregnancy and cardiovascular disease
Ramlakhan, K. P., Johnson, M. R., & Roos-Hesselink, J. W. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0390-z · Cited by 284
Baz, B., Riveline, J.-P., & Gautier, J.-F. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0378 · Cited by 260
Farahvar, S., Walfisch, A., & Sheiner, E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1476135 · Cited by 237
Future risk of diabetes in mother and child after gestational diabetes mellitus
Damm, P. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.11.025 · Cited by 223
Self-citationLong-Term Effects of Pregnancy Complications on Maternal Health: A Review
Neiger, R. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080076 · Cited by 212
“In glucose-tolerant women, the prevalence was doubled in the prior GDM group, compared with control group [12].”
MethodResultRetnakaran, R., & Shah, B. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090569 · Cited by 194
Pregnancy as a window to future health: Excessive gestational weight gain and obesity
Gilmore, L. A., Klempel-Donchenko, M., & Redman, L. M. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.05.009 · Cited by 193
“metabolic syndrome development by 10 years postpartum.(64,65) Metabolic syndrome is characterized by abdominal obesity, abnormal lipid parameters, elevated blood pressure and serum plasma glucose, and insulin resistance,(66) which are symptoms that can easily develop in the pregnant state.”
Glucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Zinman, B., & Hanley, A. J. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1990 · Cited by 190
“Nevertheless, previous studies have shown that: 1) approximately 30–40% of women with a history of GDM exhibit the metabolic syndrome by 10 yr postpartum (11, 12); and 2) women with GDM have a 70% increased incidence of CVD compared with their peers, within just 11 yr after the index pregnancy (10).”
ResultAn association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity
Kessous, R., Shoham-Vardi, I., Pariente, G., Sherf, M., & Sheiner, E. (2013) · Heart · doi:10.1136/heartjnl-2013-303945 · Cited by 193
Gestational Diabetes After Delivery
Kitzmiller, J. L., Dang-Kilduff, L., & Taslimi, M. M. (2007) · Diabetes Care · doi:10.2337/dc07-s221 · Cited by 171
“In the large 4- to 23-year follow-up program in Denmark, the prior GDM group of 481 women had 68% impaired glucose regulation, 59% elevated fasting serum insulin, 54% central obesity, 28% hypertension, and 35% dyslipidemia, mainly characterized by elevated triglycerides and reduced HDL cholesterol.”
BackgroundInfluentialRetnakaran, R., & Shah, B. R. (2017) · Diabetes Care · doi:10.2337/dc16-1400 · Cited by 167
Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087863 · Cited by 163
“Lauenborg [24] prospective study 2005 Danish 199/457 146/987 Danish NCEP-ATP III 9.”
BackgroundRecurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications
Bottalico, J. N. (2007) · Seminars in Perinatology · doi:10.1053/j.semperi.2007.03.006 · Cited by 180
The metabolic syndrome in women
Bentley–Lewis, R., Koruda, K., & Seely, E. W. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0616 · Cited by 174
“Studies have shown an increased prevalence of the metabolic syndrome in women with a history of GDM compared with those without GDM”
BackgroundCheong, J. N., Wlodek, M. E., Moritz, K. M., & Cuffe, J. S. M. (2016) · The Journal of Physiology · doi:10.1113/jp271745 · Cited by 161
“Other studies have shown that women who develop gestational diabetes have increased lifetime risk of developing overt diabetes (Kim et al. 2002; Damm, 2009) and their health can be further compromised by second hits such as obesity (Lauenborg et al. 2005).”
BackgroundGestational Diabetes: Implications for Cardiovascular Health
Sullivan, S. D., Umans, J. G., & Ratner, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0238-3 · Cited by 143
Gunderson, E. P., Jacobs, D. R., Chiang, V., Lewis, C. E., Tsai, A., Quesenberry, C. P., & Sidney, S. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.03.031 · Cited by 138
Shemer, E. A. W., Stephansson, O., Thuresson, M., Thorsell, M., Ludvigsson, J. F., & Marschall, H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.010 · Cited by 141
Lindsay, K. L., Brennan, L., Kennelly, M. A., Maguire, O. C., Smith, T., Curran, S., Coffey, M., Foley, M. E., Hatunic, M., Shanahan, F., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.008 · Cited by 157
Gestational Diabetes Mellitus and Its Implications across the Life Span
Wicklow, B. A., & Retnakaran, R. R. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0348 · Cited by 172
“In this context, it is notable that studies have consistently found that, compared to their peers, women with a history of GDM have a higher prevalence of cardiometabolic risk factors, including dyslipidemia, hypertension, overweight/obesity, and metabolic syndrome [35-39].”
BackgroundCardiovascular Complications of Pregnancy
Góngora, M. C., & WENGER, N. K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023905 · Cited by 150
“Women with GDM have a more atherogenic lipid profile by three months postpartum, characterized by increased LDL and apoB and have increased carotid intima-media thickness compared to controls [100–104].”
BackgroundFadl, H., Magnuson, A., Östlund, I., Montgomery, S., Hanson, U., & Schwarcz, E. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12754 · Cited by 110
The management of gestational diabetes
Cheung, W. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3405 · Cited by 110
“83,84 A higher prevalence of cardiovascular disease that occurs at a younger age, independent of the metabolic syndrome and type 2 diabetes has also been demonstrated.”
Hedderson, M. M., & Ferrara, A. (2008) · Diabetes Care · doi:10.2337/dc08-1193 · Cited by 110
“Several studies have shown women with a history of GDM are more likely to have features of the metabolic syndrome, including high blood pressure, in the years after delivery (2-5).”
BackgroundThe clinical content of preconception care: women with chronic medical conditions
Dunlop, A. L., Jack, B. W., Bottalico, J. N., Lu, M., James, A., Shellhaas, C., Hallstrom, L. H.-K., Solomon, B. D., Feero, W. G., Menard, M. K., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.08.031 · Cited by 113
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Hanley, A. J., & Zinman, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0361 · Cited by 97
“Several studies have shown that women with a history of GDM have an increased risk of the metabolic syndrome within the first decade postpartum (22, 23), and we have shown that this risk exists as early as 3 months postpartum (11).”
BackgroundGender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
Meloni, A., Dessalvi, C. C., Cugusi, L., Donataccio, M. P., Deidda, M., Sciomer, S., Gallina, S., Vassalle, C., Moscucci, F., Mercuro, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021588 · Cited by 122
López‐Tinoco, C., Roca, M., Fernández‐Deudero, Á., García-Valero, A., Bugatto, F., Aguilar‐Diosdado, M., & Bartha, J. L. (2011) · Cytokine · doi:10.1016/j.cyto.2011.12.004 · Cited by 111
Sheiner, E. (2020) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2020.546256 · Cited by 122
Vambergue, A., Dognin, C., Boulogne, A., Réjou, M. C., Biausque, S., & Fontaine, P. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02306.x · Cited by 89
Pirkola, J., Pouta, A., Bloigu, A., Miettola, S., Hartikainen, A.-L., Järvelin, M.-R., & Vääräsmäki, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1075 · Cited by 88
“Overweight is a strong risk factor for GDM (15, 16), and it associates with diabetes and metabolic syndrome in women with a history of GDM (7, 17, 18).”
BackgroundMechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88
Maternal lipid profiles in women with and without gestational diabetes mellitus
Wang, J., Li, Z., & Lin, L. (2019) · Medicine · doi:10.1097/md.0000000000015320 · Cited by 110
“Women with GDM are at highly increased risk of developing metabolic diseases after pregnancy including hyperlipidemia, type 2 diabetes, and so on.([32,33]) There have been extensive studies about circulating lipid patterns in GDM vs normal pregnancy, with no consistent conclusions.”
BackgroundC‐reactive protein and metabolic syndrome in women with previous gestational diabetes
Di Cianni, G., Lencioni, C., Volpe, L., Ghio, A., Cuccuru, I., Pellegrini, G., Benzi, L., Miccoli, R., & Del Prato, S. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.661 · Cited by 84
Hyperglycemia in pregnancy and its implications for a woman’s future risk of cardiovascular disease
Retnakaran, R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.008 · Cited by 81
Microcirculation and the Metabolic Syndrome
Wiernsperger, N. F., Nivoit, P., Kraemer‐Aguiar, L. G., & Bouskela, E. (2007) · Microcirculation · doi:10.1080/10739680701285617 · Cited by 86
“In another survey with a mean follow-up of about 10 years, prevalence of MS was 3fold higher in lean and 7-fold higher in obese subjects with previous GDM [220].”
BackgroundInfluentialPrevious Gestational Diabetes Mellitus and Markers of Cardiovascular Risk
Vrachnis, N., Augoulea, A., Iliodromiti, Z., Lambrinoudaki, I., Sifakis, S., & Creatsas, G. (2012) · International Journal of Endocrinology · doi:10.1155/2012/458610 · Cited by 81
Noctor, E., Crowe, C., Carmody, L. A., Kirwan, B., O’Dea, A., Glynn, L. G., McGuire, B. E., O’Shea, P. M., & Dunne, F. P. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0621-z · Cited by 79
Shek, N. W. M., Ngai, C. S. W., Lee, C. P., Chan, J. Y. C., & Lao, T. T. H. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2971-0 · Cited by 80
Verier‐Mine, O. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.011 · Cited by 78
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Endocrine · doi:10.1007/s12020-020-02492-1 · Cited by 83
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
Burlina, S., Dalfra, M., Chilelli, N. C., & Lapolla, A. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2070926 · Cited by 76
“1% in a control population [10–12].”
Women-specific predictors of cardiovascular disease risk - new paradigms
Maffei, S., Guiducci, L., Cugusi, L., Dessalvi, C. C., Deidda, M., Gallina, S., Sciomer, S., Gastaldelli, A., & Kaski, J. C. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.005 · Cited by 75
Foghsgaard, S., Andreasen, C. H., Vedtofte, L., Andersen, E. S., Bahne, E., Strandberg, C., Buhl, T., Holst, J. J., Svare, J., Clausen, T. D., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1017 · Cited by 77
“tained, these women are more prone to themetabolic syndrome than thosewho had NGT during pregnancy (15).”
BackgroundSelf-citationOgonowski, J., & Miazgowski, T. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.003 · Cited by 72
Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications
Lee, J., Lee, N. K., & Moon, J. H. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2264 · Cited by 101
“Several follow-up studies have shown that women with a prior history of GDM are at an increased future risk of developing metabolic syndrome [68,69], which is strongly linked to CVD [70].”
Mousa, S., Brady, Mousa, S., & Mousa (2009) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s4388 · Cited by 63
“Physicians must provide early intervention and long-term monitoring for women with PCOS and need to continue this lifelong monitoring; these patients are at increased risk for complications as they age, as body mass index increases, and in the presence of diabetes.(56,57) Early treatment is the key with these patients…”
Appiah, D., Schreiner, P. J., Gunderson, E. P., Konety, S. H., Jacobs, D. R., Nwabuo, C. C., Ebong, I. A., Whitham, H. K., Goff, D. C., Lima, J. A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1759 · Cited by 63
“alies (32,33), increased insulin resistance (35), and elevated inflammatory marker”
BackgroundHollman, G., & Kristenson, M. (2008) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2007.05.003 · Cited by 61
“8% [28] in contrast to our result of 10% in the age group 45–49-year-old women.”
ResultPrevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus
Lee, H., Jang, H. C., Park, H. K., Metzger, B. E., & Cho, N. H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.02.017 · Cited by 61
Rawal, S., Olsen, S. F., Grunnet, L. G., Ronald, C. W., Hinkle, S. N., Granström, C., Wu, J., Yeung, E. H., Mills, J. L., Zhu, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2629 · Cited by 65
Self-citationPrediction of developing metabolic syndrome after gestational diabetes mellitus
Akıncı, B., Çeltik, A., Yener, S., & Yeşil, S. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.007 · Cited by 68
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09587-0 · Cited by 65
Luoto, R. M., Kinnunen, T. I., Aittasalo, M., Ojala, K., Mansikkamäki, K., Toropainen, E., Kolu, P., & Vasankari, T. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-39 · Cited by 58
“In a Danish sample (N = 481), the prevalence of metabolic syndrome approximately 10 years after pregnancy was three times as high in women with prior diet-treated GDM as in 1000 age-matched populationbased control subjects [ 10 ].”
Huvinen, E., Eriksson, J. G., Koivusalo, S. B., Grotenfelt, N., Tiitinen, A., Stach-Lempinen, B., & Rönö, K. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1118-y · Cited by 55
Bomback, A. S., Rekhtman, Y., Whaley-Connell, A. T., Kshirsagar, A. V., Sowers, J. R., Chen, S.-C., Li, S., Chinnaiyan, K. M., Bakris, G. L., & McCullough, P. A. (2010) · Diabetes Care · doi:10.2337/dc10-1095 · Cited by 55
Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study
Koo, B. K., Lee, J. H., Kim, J., Jang, E. J., & Lee, C.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153107 · Cited by 55
“A history of GDM increases the subsequent risk of metabolic syndrome [11, 12], type 2 diabetes (T2D) [13], and subclinical atherosclerosis [14], even in young women.”
BackgroundSkajaa, T., Fuglsang, J., Knorr, S., Møller, N., Ovesen, P., & Kampmann, U. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001728 · Cited by 82
Lohse, N., Marseille, E., & Kahn, J. G. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(11)60007-6 · Cited by 54
“A woman with GDM has a 70% risk of type 2 diabetes in 10 years [30], a 38% risk of metabolic syndrome [31], and a 1.”
BackgroundThe metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus
Chatzi, L., Plana, E., Pappas, A. C., Alegkakis, D., Karakosta, P., Daraki, V. N., Vassilaki, M. E., Tsatsanis, C., Kafatos, A., Koutis, A., et al. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.07.003 · Cited by 55
Keely, E. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2274 · Cited by 51
Increasing Incidence of Gestational Diabetes Mellitus in Louisiana, 1997–2009
Wang, Y., Chen, L., Xiao, K., Horswell, R., Besse, J., Johnson, J., Ryan, D. H., & Hu, G. (2012) · Journal of Women's Health · doi:10.1089/jwh.2011.2838 · Cited by 51
Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
Lekva, T., Bollerslev, J., Norwitz, E. R., Aukrust, P., Henriksen, T., & Ueland, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136892 · Cited by 57
“Our finding of dyslipidemia in women with GDM at 5-year follow-up, which was more pronounced based on the old WHO diagnostic criteria for GDM, and in women with a more severe glucose intolerance during pregnancy, are consistent with a number of other studies demonstrating an atherogenic lipid profile in such women [36…”
ResultCardiometabolic Consequences of Gestational Dysglycemia
Brewster, S., Zinman, B., Retnakaran, R. R., & Floras, J. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.080 · Cited by 54
“Postpartum metabolic syndrome in DM has been well described (25,26).”
Backgrounddos Santos-Weiss, I. C. R., Rea, R. R., Fadel-Picheth, C. M. T., Rego, F. G. D. M., Pedrosa, F. D. O., Gillery, P., de Souza, E. M., & Picheth, G. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.004 · Cited by 52
Associations between the chemical composition of PM2.5 and gestational diabetes mellitus
Zheng, Y., Wen, X., Bian, J., Lipkind, H. S., & Hu, H. Z. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110470 · Cited by 51
Obesity, Persistent Organic Pollutants and Related Health Problems
Vassilopoulou, L., Psycharakis, C., Petrakis, D., Tsiaoussis, J., & Tsatsakis, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_4 · Cited by 52
“The predominant diseases associated with obesity pertain to insulin resistance and type 2 diabetes (Lauenborg et al. 2005), ovarian abnormalities, non-alcoholic fatty liver disease Chen et al. (2011), Rantakokko et al. (2015) renal dysfunction (Mathew et al. 2011) and male infertility (Kasturi et…”
BackgroundPregravid cardiometabolic risk profile and risk for gestational diabetes mellitus
Hedderson, M. M., Darbinian, J. A., Quesenberry, C. P., & Ferrara, A. M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.037 · Cited by 52
High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes
Shen, Y., Li, W., Leng, J., Zhang, S., Liu, H., Li, W., Wang, L., Tian, H., Chen, J., Qi, L., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.03.030 · Cited by 49
“[24] When in a rather shorter postpartum period (3 months), the risk of the metabolic syndrome was reported to be twofold higher in women with GDM compared with the control population of normal glucose during pregnancy in Canada with a small proportion of Asian women (16.”
BackgroundThe role of obstructive sleep apnea in metabolic syndrome: A population-based study in women
Theorell‐Haglöw, J., Berne, C., Janson, C., & Lindberg, E. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.06.014 · Cited by 51
“This is comparable with reports from studies of women selected from a general population, where a prevalence of 13–38% has been reported [19,20].”
ResultPintaudi, B., Di Vieste, G., Corrado, F., Lucisano, G., Pellegrini, F., Giunta, L., Nicolucci, A., D'Anna, R., & Di Benedetto, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0759 · Cited by 44
The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
Nogueira, A. I., Santos, R. A. S., Silva, A. C. S. E., Cabral, A. C. V., Vieira, R. L. P., Drumond, T. C., Machado, L. J. D. C., Freire, C. M. V., & Ribeiro‐Oliveira, A. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.014 · Cited by 45
Tranidou, A., Dagklis, T., Tsakiridis, I., Siargkas, A., Apostolopoulou, A., Mamopoulos, A., Goulis, D. G., & Chourdakis, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01464-6 · Cited by 43
Gjesing, A. P., Rui, G., Lauenborg, J., Have, C. T., Hollensted, M., Andersson, E., Grarup, N., Sun, J., Quan, S., Brandslund, I., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00040 · Cited by 43
“GADAswere detected by a radioimmunoassay [7, 20].”
Self-citationHealth Behaviours of Postpartum Women with a History of Gestational Diabetes
Evans, M. K., Patrick, L. J., & Wellington, C. M. (2010) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(10)43011-7 · Cited by 47
Nutrition and Pregnancy Outcome
Henriksen, T. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00241.x · Cited by 42
Cianni, G. D., Ghio, A., Resi, V., & Volpe, L. (2010) · Women s Health · doi:10.2217/whe.09.76 · Cited by 52
“As a consequence, MS prevalence after a GDMcomplicated pregnancy is significantly higher than in women with normal pregnancy, in just the first 10 years following the index pregnancy (Figure 3) [35–37].”
BackgroundAssociation of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size
Qiu, C., Rudra, C., Austin, M., & Williams, M. (2007) · Physiological Research · doi:10.33549/physiolres.931073 · Cited by 41
“Notably, some investigators attributed the increased risk of developing type 2 diabetes mellitus and hypertension in women with history of GDM to their dyslipidemic profiles (Enquobahrie et al. 2005, Lauenborg et al. 2005, AbouGhalia et al. 2003).”
BackgroundXiang, A. H., Hodis, H. N., Kawakubo, M., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Liu, C., Ci-hua, L., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.016 · Cited by 43
The risk of metabolic syndrome in women with previous GDM in a long-term follow-up
Hakkarainen, H., Huopio, H., Cederberg, H., Pääkkönen, M., Voutilainen, R., & Heinonen, S. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1198764 · Cited by 39
“Our results are in agreement with previous studies having shown that women with a history of GDM are at increased risk for developing MetS [4,14,15,17,18].”
ResultTam, W. H., Yang, X. L., Chan, J. C. N., Ko, G. T. C., Tong, P. C. Y., Ma, R. C. W., Cockram, C. S., Sahota, D., & Rogers, M. S. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.741 · Cited by 40
“While Lauenborg and colleagues have shown that a history of gestational diabetes confers a 3-fold increased risk of MetS [10], Albareda and colleagues showed risk association with only some components of the MetS [11].”
BackgroundMadarász, E., Tamás, G., Tabák, Á. G., & Kerényi, Z. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.001 · Cited by 44
Hypertension in diabetic pregnancy: impact and long-term outlook
Colatrella, A., Loguercio, V., Mattei, L., Trappolini, M., Festa, C., Stoppo, M., & Napoli, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.003 · Cited by 42
Yefet, E., Schwartz, N., Sliman, B., Ishay, A., & Nachum, Z. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0881-6 · Cited by 43
Edalat, B., Sharifi, F., Badamchizadeh, Z., Hossein-Nezhad, A., Larijani, B., Mirarefin, M., & Fakhrzadeh, H. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-8 · Cited by 37
“In this investigation the prevalence of MS in women with pGDM was about three folds higher than the control group, which is in concordance with the findings of other studies such as Lauenborg’s [24].”
ResultRees, S., Chadha, R., Donovan, L., Guitard, A. L. T., Koppula, S., Laupacis, A., Simpson, S., & Johnson, J. A. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.219 · Cited by 40
Preeclampsia and gestational diabetes mellitus: Pre-conception origins?
Wen, S. W., Xie, R., Tan, H., Walker, M. C., Smith, G. N., & Retnakaran, R. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.019 · Cited by 39
“and the clinical syndromes disappear after delivery; many risk factors such as obesity, elevated blood pressure, dyslipidemia, insulin resistance, and hyperglycemia, are associated with both PE and GDM; and patients with a history of PE or GDM have increased risk of developing cardiovascular disease as compared to wom…”
Metadata
- Authors
- Lauenborg, J., Mathiesen, E., Hansen, T., Glümer, C., Jørgensen, T., Borch-Johnsen, K., Hornnes, P., Pedersen, O., & Damm, P.
- Affiliations
- Copenhagen University Hospital (DK)
- Steno Diabetes Center (T.H., C.G., K.B.-J., O.P.), 2820 Gentofte, Denmark;
- Glostrup Hospital (DK)
- Departments of Obstetrics (J.L., P.H., P.D.), 2100 Copenhagen, Denmark;
- Corresponding author
- Lauenborg, Jeannet
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 4004-4010
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2060336430
- Cited by
- 279
- References
- 39
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 20 · 2021: 6 · 2020: 12 · 2019: 18 · 2018: 16 · 2017: 18 · 2016: 16 · 2015: 17 · 2014: 8 · 2013: 18 · 2012: 13
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- World Health Organization
- Dagmar Marshalls Fond
- Sundhed og Sygdom, Det Frie Forskningsråd
- Gentofte Hospital
- Rigshospitalet
- Diabetesforeningen
- Medical Research Council
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- metabolic syndrome, gestational diabetes mellitus, postpartum women, obesity, insulin resistance, glucose tolerance, body mass index, lipid profile, blood pressure, long-term follow-up
- MeSH terms
- Adult, Female, Humans, Middle Aged, Pregnancy, Prevalence, Diabetes, Gestational, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.